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Sucrose intake lowers μ-opioid and 
dopamine D2/3 receptor availability 
in porcine brain
Michael Winterdahl1, Ove noer1, Dariusz orlowski2, Anna c. Schacht1, Steen Jakobsen1, 
Aage K. o. Alstrup1, Albert Gjedde  1,3,4,5 & Anne M. Landau  1,6*
Excessive sucrose consumption elicits addiction-like craving that may underpin the obesity epidemic. 
Opioids and dopamine mediate the rewarding effects of drugs of abuse, and of natural rewards from 
stimuli such as palatable food. We investigated the effects of sucrose using PET imaging with [11c]
carfentanil (μ-opioid receptor agonist) and [11C]raclopride (dopamine D2/3 receptor antagonist) in seven 
female anesthetized Göttingen minipigs. We then gave minipigs access to sucrose solution for one hour 
on 12 consecutive days and performed imaging again 24 hours after the final sucrose access. In a smaller 
sample of five minipigs, we performed an additional [11C]carfentanil PET session after the first sucrose 
exposure. We calculated voxel-wise binding potentials (BPnD) using the cerebellum as a region of non-
displaceable binding, analyzed differences with statistical non-parametric mapping, and performed 
a regional analysis. After 12 days of sucrose access, BPnD of both tracers had declined significantly in 
striatum, nucleus accumbens, thalamus, amygdala, cingulate cortex and prefrontal cortex, consistent 
with down-regulation of receptor densities. After a single exposure to sucrose, we found decreased 
binding of [11C]carfentanil in nucleus accumbens and cingulate cortex, consistent with opioid release. 
The lower availability of opioid and dopamine receptors may explain the addictive potential associated 
with intake of sucrose.
Five percent of the world’s population are clinically obese1. As a hallmark of the metabolic syndrome, obesity is 
associated with type 2 diabetes, cardiovascular disease, respiratory problems, and risk of depression and possi-
bly dementia2. The increased consumption of energy dense foods has exaggerated the physiologic distinction 
between homeostatic hunger that follows food deprivation, and hedonic hunger, or “craving”, which occurs in the 
absence of deprivation3,4. As the homeostatic regulation alone cannot account for the current rise in obesity, it 
is mandatory to test the effect on brain mechanisms of reward and pleasure of the addictive properties of highly 
palatable food.
Sucrose consumption is associated with obesity, and sucrose is increasingly considered an addictive sub-
stance5. Some findings are at variance with this claim due to difficulties in separating non-palatable food con-
sumption from hedonic food responses, and in determining the addictive ingredient in processed food, as well as 
the different mechanisms by which food alters brain circuitry through natural pathways6. Nevertheless, in specific 
contexts, intake of sucrose does induce reward and craving, comparable in magnitude to those induced by addic-
tive drugs, that lead to overconsumption and eventual obesity6,7.
Hunger is associated with “wanting” that is closely related to effects of dopaminergic neurotransmission in 
a number of reward circumstances8, but it remains unclear how the action of dopamine (DA) is modulated in 
response to compulsive eating. Consumption of palatable food is linked to “liking”, mediated primarily by the 
endogenous opioid system, especially the μ-opioid receptor (μOR)9,10, which can promote overconsumption 
when deregulated. In the present report, we test the claim that sucrose leads to opioid and dopamine release that 
lowers the availability of μOR and DA D2/3 receptors. The availability is an index of the number of unoccupied 
receptors available for tracer binding and in principle does not distinguish between ligand occupancy and recep-
tor density11.
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The onset of compulsive eating depends on multiple factors, and causal studies in humans raise ethical issues. 
The majority of studies therefore focus on feeding behavior in rats12. Although rats have a “sweet tooth”, their 
homeostatic mechanisms important to weight gain, metabolism, and type of fat accumulation, differ significantly 
from those of humans. The Göttingen minipig is a large omnivorous animal with a well-developed gyrencephalic 
brain, which can be imaged at sufficient resolution. Its well-defined subcortical and prefrontal cortical regions13 
enable a more direct translation to human brain function. Here, we use positron emission tomography (PET) 
imaging to test in vivo μOR and DA D2/3 availability in a minipig model of subchronic sucrose exposure. In 
a smaller sample, we investigated the immediate effects on μOR occupancy after the first exposure to sucrose. 
Finally, we tested the relationship between the changes in receptor availability of the two tracers.
Results
Average parametric maps of [11C]carfentanil and [11C]raclopride binding potential (BPND) are shown in Fig. 1. 
To analyze the changes occurring after the first sucrose exposure in five minipigs compared to baseline, and 
one day after the 12th sucrose access in seven minipigs compared to baseline, we used permutation theory and 
non-regionally restricted whole-brain analysis, the preferred method for samples of this size14.
initial sucrose exposure. In the five minipigs imaged with [11C]carfentanil at baseline and immediately 
after the first sucrose exposure, we found significantly reduced tracer binding in the anterior cingulate cortex and 
the nucleus accumbens in response to sucrose, shown in color in Fig. 2, indicating p < 0.05. We detected as much 
as 14% decreased tracer binding in both areas compared to baseline.
12 days of sucrose access. We then performed the analysis of seven minipigs imaged with [11C]carfentanil 
at baseline and after 12 days of sucrose access and found significantly reduced tracer binding in sucrose-exposed 
animals compared to baseline. The most highly significantly affected regions are shown in red in Fig. 3 (p < 0.01) 
and include parts of the olfactory structures, nucleus accumbens/ventral striatum and the temporal cortex/lobe, 
followed by areas shown in yellow (p < 0.015) which included parts of the prefrontal cortex, cingulate cortex, 
amygdala and brainstem. In order to obtain BPND values and assess percent change, we performed regional anal-
ysis and obtained mean values in each region at baseline and after sucrose consumption (Fig. 4).
We used [11C]raclopride as the tracer of DA D2/3 receptors in striatal and extrastriatal brain regions in mini-
pigs at baseline and after 12 days of sucrose access (Fig. 1). We found decreased tracer binding in sucrose-exposed 
Figure 1. Average voxel-wise non-displaceable binding potential (BPND) maps superimposed on MRI images 
in sagittal view. Data are presented for [11C]carfentanil BPND of the 5 minipigs imaged at baseline, after initial 
exposure to sucrose and after 12 days of sucrose exposure (top row). [11C]carfentanil BPND of all 7 minipigs 
imaged at baseline and after 12 days of sucrose access are presented in the middle row. [11C]raclopride BPND of 
all 7 minipigs imaged at baseline and after 12 days of sucrose access are shown in the bottom row. Note that the 
color scale is exponential to highlight the [11C]raclopride BPND in extrastriatal regions.
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animals, compared to baseline with largest effects (p < 0.01) in areas of the prefrontal cortex, nucleus accumbens/
ventral striatum, cingulate cortex, amygdala, thalamus, mesencephalon, hippocampal regions, and olfactory areas 
(Fig. 5). Data from regional analysis are presented in Fig. 6.
Correlations between [11C]raclopride and [11C]carfentanil data. We tested the potential correlation 
between [11C]raclopride and [11C]carfentanil values of BPND in striatal and non-striatal regions in minipigs at base-
line and after 12 days of sucrose intake, with no associations observed. We then tested whether declines of tracer 
binding were correlated, and we compared the changes of BPND for [11C]raclopride with the changes of BPND for 
[11C]carfentanil only in the minipigs that had lower BPND of both tracers after sucrose intake (n = 6). We found 
significant negative correlations in averaged extrastriatal (r2 = 0.91, p < 0.01), but not in striatal, regions (Fig. 7).
Discussion
We determined the effects of repeated intermittent access to sucrose on opioid and DA neurotransmission in 
mammalian brain. Longitudinal in vivo PET imaging of the μOR and DA D2/3 receptors revealed reduced recep-
tor availability throughout the reward circuit, including the nucleus accumbens, prefrontal cortex, and the ante-
rior cingulate cortex. The results clearly demonstrate that sucrose affects reward mechanisms in a manner similar 
to that of drugs of abuse.
Figure 2. Significant decreases in [11C]carfentanil BPND after the first sucrose water exposure compared to 
baseline (n = 5). Only voxels with significant (p < 0.05) decreases are shown as colored areas projected onto 
T1 weighted MRI cuts at the level of the anterior cingulate cortex (left) and nucleus accumbens (middle) from 
a stereotaxic minipig brain atlas. Note that the maximum significance level achievable with 5 animals is 2−5 
≈ 0.031 (see color bar). Data are presented on coronal sections of the pig brain at the levels indicated on the 
sagittal image (right).
Figure 3. Significant decreases in [11C]carfentanil binding potential (BPND) between baseline and after 12 days 
of sucrose water exposure (n = 7). The voxels with significant (p < 0.05) decreases are shown as colored areas 
projected onto T1 weighted MRI cuts from a stereotaxic minipig brain atlas. Data are presented on coronal 
brain sections at the levels indicated on the sagittal image (bottom right). Note that the maximum significance 
level achievable with 7 animals is 2−7 ≈ 0.0078 (see color bar).
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The intake of sucrose as a palatable substance is known to release DA and induce dependency in rodents15, 
with sucrose shown to be even more pleasurable than cocaine in rodents in certain contexts. Thus, rodents work 
more intensely to obtain sucrose than cocaine, even in the absence of food deprivation5. However, the effects of 
sucrose are regulated both by the homeostatic system and by hedonic reward circuits16,17 that may mediate the 
distinction between nutritional and hedonic aspects of sucrose action18. We opted for a one-hour per day sched-
ule in order to promote “binging”, as previous studies in rats had revealed a higher intake during the first hour of 
daily access in an intermittent schedule15,19. Behavioral studies of food intake often target food-restricted animals, 
but the design may not necessarily reflect the same neural mechanisms active in obesity. Pigs in the present study 
were not food restricted and were fed the usual amounts of their normal diet in addition to access to sucrose.
Opioid receptors (OR) are widely expressed in the brain, specifically in structures known to modulate eat-
ing and reward processes20. ORs have been shown to be important in the rewarding and relapsing effects of 
cocaine21–24. Alterations in binding have also been linked to the homeostatic responses to eating and the pleasure 
associated with palatable food25. In particular, “liking” of food is linked to the endogenous opioid system, espe-
cially the μOR9,10 in the shell of the nucleus accumbens and the ventral pallidum26. Infusions of a μOR agonist into 
distinct portions of the nucleus accumbens and ventral pallidum strongly enhance “liking” behaviors, including 
tongue protrusions and paw licking, following increased palatable intake of food27–29. Further evidence for opioid 
signaling in the processing of hedonic regulation comes from μOR antagonists that attenuate consumption of 
Figure 4. Regional analysis of [11C]carfentanil binding potential (BPND) between baseline and after 12 days of 
sucrose water exposure (n = 7). Data are presented as means ± standard error.
Figure 5. Significant decreases in [11C]raclopride binding potential (BPND) between baseline and after 12 days 
of sucrose water exposure (n = 7). The voxels with significant (p < 0.05) decreases are shown as colored areas 
projected onto T1 weighted MRI cuts from a stereotaxic minipig brain atlas. Data are presented on coronal 
sections of the pig brain at the levels indicated on the sagittal image (bottom right). Note that the maximum 
significance level achievable with 7 animals is 2−7 ≈ 0.0078 (see color bar).
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Figure 6. Regional analysis of [11C]raclopride binding potential (BPND) between baseline and after 12 days of 
sucrose water exposure (n = 7). Data are presented as means ± standard error.
Figure 7. Correlations between pre- minus post- declines of [11C]raclopride and [11C]carfentanil binding 
potentials (BPND) in minipigs with decreased tracer binding after sucrose intake (n = 6). Data from the averaged 
extrastriatal regions (top) and striatum (bottom) are presented. The coefficient of determination (r2) and the p 
values are shown for each graph.
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palatable chow in both ad libitum-fed and food restricted animals, but with a more limited effect on the intake 
of non-palatable standard pellets30,31. In humans, μOR antagonists decrease short-term food intake and reduce 
pleasantness of palatable foods32–34. Opioid signaling in the basolateral amygdala also contributes to food “want-
ing” through modulation of reward seeking and the incentive value of food35.
With [11C]carfentanil, we obtained images of tracer binding that is sensitive both to μOR levels and to the 
brain’s release of endogenous opioids36,37. We detected immediate loss of μOR availability in areas of the nucleus 
accumbens and anterior cingulate cortex, specific brain regions of the reward pathway, after initial consump-
tion of sucrose by five minipigs, consistent with endogenous opioid release. Previous studies have shown that 
palatable food can lead to feelings of pleasure38 by stimulating opioid release. After 12 days of sucrose access, we 
observed decreased [11C]carfentanil binding, which has several possible explanations39 including endogenous 
opioid release and binding to μOR, μOR internalization as a result of increased opioid binding, and increased DA 
D2/3 receptor activation leading to heterologous desensitization of μOR40.
In support of the present findings, [11C]carfentanil studies of patients with bulimia41, obesity42–44, and 
binge-eating disorder45, show decreased receptor availability. However, these are chronic conditions whereas the 
minipigs only received sucrose for 12 days. In a study of acute feeding behavior in healthy men, feeding led to 
robust and widespread endogenous cerebral opioid release, both in the presence and absence of hedonia, suggest-
ing that opioid release reflects metabolic and homeostatic, as well as hedonic, responses25. This study, together 
with another that imaged patients after a chocolate-flavored liquid meal44, is directly relevant to the acute study 
of five minipigs after the first sucrose exposure, but is different from the subchronic sucrose-exposure study over 
12 days where the reduced receptor availability more likely reflects repeated overstimulation and concomitant 
downregulation of μOR.
The prefrontal cortex is important in decision-making and ascribing value to items and therefore the μOR in 
the prefrontal cortex may be accountable for the altered evaluation of food saliency, which can raise the addictive 
potential of food. We have found decreased binding in the prefrontal cortex, consistent with previous studies 
showing that high fat diet reduces levels of μOR mRNA in the prefrontal cortex46 and that infusion of a μOR 
agonist in the prefrontal cortex increases intake of sweet food47. Again, however, the issue arises whether the 
high fat diet is a more chronic condition that more likely mediates receptor down-regulation, compared to the 
shorter-term sucrose-feeding design, suggesting sustained release of endogenous opioids that displaces tracer 
carfentanil bound to μOR, even after 12 days of sucrose.
DA has been implicated in rewards both from drugs and behavior. Chronic cocaine use has been found to 
inhibit DA signaling48. DA D1 and D2/3 receptor levels are altered by nicotine in pig brain49, and in non-human 
primates with a history of cocaine abuse50, consistent with the downregulation of D2/3 receptors in the brains of 
human cocaine addicts51,52. As for drugs of abuse, sucrose has been shown to upregulate DA D1 receptors19 and 
increase DA release53, reinforcing the role of DA in “wanting” in relation to palatable food. Previous PET studies 
have demonstrated a decrease in striatal DA D2/3 receptor availability in morbid obesity vs average weight54,55, 
similar in magnitude to the reduction in drug-addicted patients56, and in animal with models of obesity57. In 
rodent studies, D2/3 receptor knockdown in the striatum promotes the development of compulsive food seeking 
in rats with access to palatable food57.
Our observations of decreased D2/3 receptor availability of the pig may indicate increased DA levels in 
response to the incentive salience associated with the sucrose intake since DA is released as part of the wanting 
of drugs of abuse and other pleasurable activities52,58–60. As the pigs were anesthetized during the imaging, and 
had not received sucrose in 24 hours, the decreased D2/3 BPND more likely reflects a reduction in the number 
of receptors in response to prolonged increase of DA release at each of the 12 days of sucrose access. The reduc-
tion can raise brain reward thresholds, associated with down-regulation of striatal DA D2 receptors. This may 
explain the increased susceptibility to drugs of abuse seen in previous studies of rats overeating sucrose that led to 
cross-sensitization to cocaine, hyperactivity after low dose amphetamine, increased alcohol intake when abstain-
ing from sucrose, and tolerance to the analgesic effects of opiates6.
A previous study of obesity in the Göttingen minipig identified decreased cerebral blood flow in the nucleus 
accumbens, ventral tegmental area (VTA) and prefrontal cortex, with single photon emission computed tomog-
raphy (SPECT) of brain61. Consistent with these findings, we observed reduced DA D2/3 binding in the ventro-
forebrain region containing the nucleus accumbens and in the prefrontal cortex. Extracellular levels of DA are 
increased 3-fold in the nucleus accumbens after sucrose intake in freely-moving rats undergoing microdialy-
sis62. In sucrose dependent animals, repeated sucrose intake can lead to release of DA from the shell of nucleus 
accumbens63. Animals fed a restricted diet with limited access to sucrose had lower DA D2 receptor binding in 
the nucleus accumbens shell and the dorsal striatum64. Restricted high fat and sucrose diets can lead to sustained 
downregulation of D1 and D2 receptor mRNA in the nucleus accumbens65. A microdialysis study of the effects 
of palatable food revealed increased DA release in the nucleus accumbens and prefrontal cortex when the food 
was still considered novel; once the rats were accustomed to the new food, the increased release was blunted in 
the nucleus accumbens, but not in the prefrontal cortex66. The differential susceptibility to habituation and condi-
tioning of the activity in two regions may explain the larger increase observed in prefrontal cortex than in nucleus 
accumbens of minipigs exposed to the same palatable substance that lost novelty after twelve days. However, as we 
did not image minipigs with [11C]raclopride after the first sucrose administration, this explanation is speculative.
The prefrontal cortex modulates executive function, decision-making, and self-control67. Dysfunctional DA 
neurotransmission in the prefrontal cortex impairs modulation of reward processing, suggesting impaired exec-
utive function and decision-making skills in obese individuals68,69. Moreover, a human PET study correlated 
decreased frontal cortex metabolism with decreased striatal D2 binding in obesity70. Here, we find reduced D2/3 
receptor availability in the prefrontal cortex including the orbitofrontal cortex of pigs exposed to the sucrose 
regimen.
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Dopaminergic neurons of the VTA send projections to the hippocampus and amygdala, where they support 
habit-like behaviors71 and mediate the encoding and retrieval of conditioning to drug72,73 and food cues74,75. 
Human brain imaging has shown hippocampal activation in response to food craving and tasting76. Consistent 
with our findings of a reduced hippocampal and amygdalar D2/3 receptor availability in response to sucrose, 
human brain mapping with [18F]fallypride showed cocaine cue-induced DA release in amygdala and hippocam-
pus77. In rodent brains, cocaine cue exposure triggered DA release in the amygdala78, and alterations of amygdala 
DA levels influenced cue-induced cocaine-seeking behavior79.
In a study of obese individuals, the association between D2/3 and μOR availabilities, known to exist in striatal 
regions of lean individuals, was disrupted in the ventral striatum80. We compared the values of BPND of the two 
tracers to test if the data reproduced this effect. Unlike lean humans, the present brains of pigs had no correlation 
between the values of BPND of the two tracers, at baseline or after the exposure to sucrose. We then tested whether 
the animals with the largest declines of tracer raclopride binding would also have the largest decreases of tracer 
carfentanil binding, but instead we found a negative correlation in the averaged extrastriatal regions, suggest-
ing that animals with the greatest change of the binding potential of tracer raclopride had the lowest change of 
the binding potential of tracer carfentanil. The inverse relation between the changes suggests that the effects of 
sucrose intake on the availabilities of the respective receptors are regulated in opposite directions. It is known that 
excessive consumption of palatable food, or drugs, can be driven by wanting or liking, or both60,81. It is possible 
that the magnitude of wanting driven by dopamine negates the magnitude of liking driven by opioids, or vice 
versa. Recent evidence points to roles of GABAA receptors in the VTA and cholinergic terminals in striatum and 
possibly cortex that act as switches between dopamine-dependent and dopamine-independent mechanisms of 
opioid action82,83 that may explain the reciprocity of dopamine and opioid effects in porcine extrastriatal regions 
determined here.
A shortcoming of PET, also in comparatively large animals, is the limited spatial resolution of the tomog-
raphy that affects the results from small brain regions involved in food-associated behaviors. However, despite 
these concerns, [11C]raclopride binding previously was recorded both in striatal and extrastriatal regions84–87. 
The use of [11C]raclopride to label the same type of receptors raises no concern about potential affinity differences 
that may affect the use of separate tracers for the same receptors in different regions. Recent studies included 
records of extrastriatal binding of [11C]raclopride. Alakurtti et al. found good reproducibility of measures of 
striatal raclopride binding in the striatum, with only good to moderate reproducibility in the cortex85. In a later 
study, Svensson et al. discussed several issues affecting the use of [11C]raclopride as a marker of extrastriatal D2/3 
receptors in a study of healthy humans, including poor reproducibility in cortex and limited decline of extrastri-
atal binding in frontal cortex in response to a D2/3 blocking agent88. The test-retest comparisons revealed varia-
bilities of 4–7% in striatum and 13–59% in cortical regions, but the time between examinations averaged 20 days, 
unlike the more informative 1–2 days of most studies. A number of factors in the lives of those subjects may have 
had time to influence the findings. Indeed, we show here that merely adding sucrose consumption to a morning 
routine for 12 days may have influenced binding measures obtained two weeks later. Other factors as common as 
playing video games, shopping, entering new romantic relationships and sexual activity, using drugs or changing 
diet and exercise may influence extrastriatal dopamine levels with potential for great variation of datasets. The 
current study in minipigs introduced a well-controlled set-up with the only variable being the absence or pres-
ence of sucrose in the diet. In this context, the data from seven animals had sufficiently low variability in relevant 
extrastriatal regions to identify a statistically significant reduction of binding in response to sucrose.
A limitation of the current study is the use of anaesthetics required to ensure immobility during in vivo imag-
ing of animals. The effects of specific anaesthetics, and their interactions with drugs or other interventions, can 
confound the binding of radioligands89,90. Ketamine is an anti-glutamatergic drug with rapid antidepressant 
effects in sub-anaesthetic doses91–93, that do not reduce striatal [11C]raclopride binding in humans94. However, 
S-ketamine was found to reduce binding availability of dopamine D2/3 receptors in striatum of conscious 
non-human primates95. Isoflurane is a common anaesthetic in animal PET. In previous studies, we found stri-
atal accumulation of [11C]SCH23390, a radioligand of the dopamine D1 receptors to be significantly higher in 
minipigs anesthetized with isoflurane rather than propofol, suggesting susceptibility of the dopaminergic neuro-
transmission to effects of anaesthesia96. In the current study, all minipigs were imaged at both timepoints under 
ketamine pre-medication and isoflurane anaesthesia, making the present comparisons valid.
conclusion
Excessive consumption of palatable food may both cause, and become the result of, addiction with direct con-
sequences to health by obesity. We tested the claim that opioids and dopamine mediate rewards, important to 
survival as well as to abuse of drugs. Minipigs with intermittent access to a sucrose solution on 12 consecutive 
days demonstrated decreased dopamine D2/3 and μ−opioid receptor availability in striatal and extrastriatal brain 
regions, implying that foods high in sucrose influence brain reward circuitry in ways similar to those observed 
when addictive drugs are consumed. Initial single exposure to sucrose was consistent with opioid release in brain 
regions active in reward. The changes of opioid and dopamine availability explain the addictive potential of 
sucrose consumed in excess.
Materials and Methods
Animal ethics. This study was approved and regulated by the Danish Animal Experiments Inspectorate and 
all experiments were carried out in accordance with the 2010/63/EU directive of the European Parliament and 
of the Council on the Protection of Animals Used for Scientific Purposes and the ARRIVE guidelines. We used 
seven fourteen-month old female Göttingen minipigs (Ellegaard, Dalmose, Denmark). Minipigs were fed a pellet 
diet (6 dL, 2 times daily, Special Diets Services, Aarhus, Denmark) with tap-water available ad libitum. The envi-
ronmental temperature was 20–22 °C, relative humidity 50–55%, and air was changed eight times every hour.
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intermittent sucrose consumption. We imaged seven minipigs with [11C]raclopride and [11C]carfentanil 
at baseline, and again one day after 12 consecutive days of sucrose water exposure. Sucrose exposure consisted of 
one hour of sucrose (sucrose, Dansukker, Copenhagen, Denmark) water access (500 grams of sucrose in 2 liters 
of water), daily during a 12-day period. The amount of sucrose intake was recorded and all minipigs consumed 
2 liters on each day. We also imaged five of the same minipigs with [11C]carfentanil, 30 minutes after the first 
sucrose access, in order to study acute opioid release.
The minipigs gained an average of 13.6% body weight from 25.4 kg (±0.73 SEM) at baseline to 28.9 kg (±0.69 
SEM) after the 12-day sucrose exposure, which was significantly higher (one-tailed t-test, p < 0.001) than the 
increases observed in a sample of control minipigs obtained in previous studies, where weights increased on 
average by only 4.9%, during the same developmental period.
Brain PET Imaging. We fasted pigs overnight with free access to water prior to imaging. We pre-medicated 
and anesthetized minipigs as described previously97 and placed them supine in a PET/CT device (Siemens 
Biograph 64 Truepoint PET). We performed a low-dose CT scan prior to each PET acquisition for anatomical 
definition and attenuation correction of PET emission data. We intravenously administered [11C]raclopride at 
baseline (360 ± 18 MBq, specific activity 77 ± 76 GBq/μmol, injected mass 0.12 ± 0.08 μg/kg) and after 12 days of 
sucrose (374 ± 54 MBq, specific activity 127 ± 85 GBq/μmol, injected mass 0.06 ± 0.05 μg/kg), and [11C]carfent-
anil at baseline (377 ± 43 MBq, specific activity 311 ± 195 GBq/μmol, injected mass 0.03 ± 0.02 μg/kg) and after 
12 days of sucrose (337 ± 71 MBq, specific activity 177 ± 157 GBq/μmol, injected mass 0.06 ± 0.08 μg/kg) via ear 
vein, in 10 mL saline, during the first minute of a 90-minute scan. We reconstructed PET data using TrueX 3D 
OSEM (3 iterations, 21 subsets), a 256 × 256 × 109 matrix, and a 2-mm Gauss filter, using a time-frame structure 
of 5 × 60, 3 × 300, 4 × 600, 2 × 900 seconds (total 14 frames, 90 minutes). At baseline and after 12 days of sucrose, 
minipigs were imaged with both tracers injected at least 100 minutes apart, due to the half-life of [11C] PET trac-
ers. Upon completion of the final PET session, we euthanized minipigs under deep anesthesia by an intravenous 
overdose of pentobarbital (100 mg/kg).
Quantitative analyses and statistics. We performed preprocessing steps using PMOD 3.7 (PMOD 
Technologies Ltd, Zurich, Switzerland). To define the stereotactic transformation parameters from time-averaged 
PET images, we used ligand-specific templates. We applied the generated transformation matrices and warping 
fields onto the corresponding dynamic PET time series. We generated parametric images of [11C]raclopride bind-
ing potential (BPND) by means of the multilinear reference tissue method of Ichise and co-workers98. We created 
a custom-made mask of the cerebellum that excluded the vermis to obtain the cerebellar tissue radioactivity over 
time in a region of negligible DA D2/3 receptor density. We generated parametric images of [11C]carfentanil using 
an implementation of the Logan reference tissue model99,100 with t* = 30 min. Studies of [11C]carfentanil binding 
in human brain have used the occipital cortex as a reference region36; however, in the pig, according to the time 
activity curves, non-displaceable binding was lower in the cerebellum than in the occipital cortex, consistent with 
findings from a rat autoradiography study101. We therefore selected the cerebellum as the reference region in the 
current study.
Statistical analysis. We subjected maps to a voxel-wise analysis with Statistical Non-Parametric Mapping 
(SnPM v13.01, http://warwick.ac.uk/snpm) SPM toolbox that utilizes non-parametric permutation theory to pro-
vide a framework for statistical inference, an approach shown to work well for small samples due to strict control 
of false positives14 and applied as previously described102. An expert in pig neuroanatomy (DO) compared the 
resulting images thresholded to 5% significance level to a high-resolution Göttingen minipig atlas103,104 to define 
and label regions of decreased DA D2/3 and μOR BPND from baseline to the post-sucrose condition. We then 
performed a region-of-interest (ROI) analysis in order to extract BPND values of specific regions found to be of 
interest based on the SnPM analysis, including the striatum, nucleus accumbens, thalamus, amygdala, cingulate 
cortex and prefrontal cortex. No additional statistics were performed on the ROI analysis, since these regions 
were already found to be significant using SnPM.
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